Infinity Pharmaceuticals (INFI)
1.09
-0.02 -1.80%
NASDAQ
Aug 17, 16:59
Delayed 2m
USD
View All Key Stats
INFI Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.40 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -69.86M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 55.25M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 0.4610 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.9380 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -9.707M |
| Return on Equity (TTM) | -- |
View All INFI News
INFI News
-
WireHeadlineTime (ET)
-
Yahoo08/12 08:36
-
PR Newswire08/11 06:15
-
Yahoo08/04 16:29
-
Yahoo08/03 23:52
-
PR Newswire08/03 16:05
-
Yahoo08/03 12:30
-
SA Breaking News08/02 17:35
-
Yahoo08/01 09:57
-
PR Newswire07/27 11:21
-
PR Newswire07/21 08:35
View All Events
INFI Events
| Date | Type | Description |
|---|---|---|
| 08/03/2017 16:30 EDT | Misc | Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Infinity Pharmaceuticals Inc Second Quarter Earnings in 2017 Release |
| 05/25/2017 | Misc | Infinity Pharmaceuticals Inc Annual General Meeting in 2016 |
| 05/09/2017 16:30 EDT | Misc | Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call in 2017 |
| 05/09/2017 | Earnings | Infinity Pharmaceuticals Inc First Quarter Earnings in 2017 Release |
| 03/14/2017 16:30 EST | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2016 |
| 03/14/2017 | Earnings | Infinity Pharmaceuticals Inc Fourth Quarter Earnings in 2016 Release |
| 01/09/2017 08:03 EDT | Misc | Infinity Announces Organizational Changes |
| 11/07/2016 16:30 EST | Misc | Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2016 |
| 11/07/2016 | Earnings | Infinity Pharmaceuticals Inc Third Quarter Earnings in 2016 Release |
INFI Fundamentals
Income Statement View Statement
INFI Ratings
Advertisement
INFI One Page Reports
- One Page Report Download
INFI Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 1.09 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.infi.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 03, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Infinity Pharmaceuticals Inc is a biopharmaceutical company engaged in discovering, developing and delivering medicines to people with difficult-to-treat diseases.
INFI Comparables
EditINFI Excel Add-In Codes
- Name: =YCI("INFI","name")
- Description: =YCI("INFI","description")
- Sector: =YCI("INFI","sector")
- Industry: =YCI("INFI","industry")
- Est. Current Fiscal Year End: =YCI("INFI","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other INFI Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INFI Tweets Stocktwits
Advertisement
